Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01948427 · ClinicalTrials.gov registry record
Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs)
A clinical trial, sponsored by Amgen.
- Terminated
- Registry status
- 203
- Enrollment target
NCT01948427 is a clinical trial that was terminated before completion, run by Amgen. The registered enrollment target is 203 participants.
The verdict
NCT01948427 was terminated before completion, sponsored by Amgen.
- TERMINATED
- Registry status
- 203 participants
- Enrollment target
Study Summary
THRIVE is an observational study that will collect information on patients with UCDs. THRIVE will follow enrolled participants for up to 10 years. As an observational study, enrolled patients will not be required to make any additional office visits or take any medicine outside of normal care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 203 participants |
| Start Date | 2013-09-25 |
| Est. Completion | 2020-02-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01948427
The ClinicalTrials.gov registry entry for NCT01948427 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 203 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Amgen, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01948427 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01948427 about?
NCT01948427 is a clinical study titled "Observational Study That Will Collect Information on Patients With Urea Cycle Disorders (UCDs)". THRIVE is an observational study that will collect information on patients with UCDs. THRIVE will follow enrolled participants for up to 10 years. As an observational study, enrolled patients will not be required to make any additional office visits or take any medicine outside of normal care.
What is the current status of trial NCT01948427?
This trial is currently terminated. The enrollment target is 203 participants. The study started on 2013-09-25. Estimated completion is 2020-02-24.
Who is sponsoring clinical trial NCT01948427?
This trial is sponsored by Amgen, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.